Truist Securities Maintains Buy on Incyte, Lowers Price Target to $91
Portfolio Pulse from jenniferd'souza@benzinga.com
Truist Securities analyst Srikripa Devarakonda maintains a 'Buy' rating on Incyte (NASDAQ:INCY) but lowers the price target from $100 to $91.

August 04, 2023 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Incyte's price target has been lowered from $100 to $91 by Truist Securities, though the 'Buy' rating is maintained.
While the lowering of the price target might initially seem negative, the maintained 'Buy' rating indicates that Truist Securities still sees potential in Incyte. This could lead to mixed reactions in the market, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100